Bharat [BIBCL] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

Bharat

BSE
Loading...

Panacea Biotec

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Bharat wins in 3 metrics, Panacea Biotec wins in 14 metrics, with 0 ties. Panacea Biotec appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBharatPanacea BiotecBetter
P/E Ratio (TTM)-5.48222.06Bharat
Price-to-Book Ratio1.163.03Bharat
Debt-to-Equity Ratio94.482.67Panacea Biotec
PEG Ratio-0.09-1.77Panacea Biotec
EV/EBITDA-7.87-195.08Panacea Biotec
Profit Margin (TTM)-241.59%1.88%Panacea Biotec
Operating Margin (TTM)-2,888.44%-5.74%Panacea Biotec
Return on Equity-21.00%-1.01%Panacea Biotec
Return on Assets (TTM)-6.28%-0.65%Panacea Biotec
Free Cash Flow (TTM)$108.92M$-776.74MBharat
1-Year Return-21.99%38.79%Panacea Biotec
Price-to-Sales Ratio (TTM)11.764.17Panacea Biotec
Enterprise Value$1.56B$24.56BPanacea Biotec
EV/Revenue Ratio20.454.03Panacea Biotec
Gross Profit Margin (TTM)N/A53.68%N/A
Revenue per Share (TTM)$2$100Panacea Biotec
Earnings per Share (Diluted)$-4.18$1.87Panacea Biotec
Beta (Stock Volatility)0.910.30Panacea Biotec
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Bharat vs Panacea Biotec Stock Performance Analysis

Loading Price Chart...

Bharat
Panacea Biotec
Bharat Stock Overview | Panacea Biotec Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bharat0.28%-1.73%-4.53%-11.28%-1.73%-13.82%
Panacea Biotec0.89%5.39%5.59%5.47%-3.12%-2.63%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bharat-21.99%-13.47%-4.44%-27.59%5.61%-10.34%
Panacea Biotec38.79%196.98%135.53%268.92%146.06%60.68%

News Based Sentiment: Bharat vs Panacea Biotec

Bharat

News based Sentiment: MIXED

The month's developments present a mixed picture for Bharat Immunologicals & Biologicals Corporation. While the share price showed a slight increase and the company continues to diversify its product line, the overall year-long decline and price volatility create uncertainty for investors.

View Bharat News Sentiment Analysis

Panacea Biotec

News based Sentiment: POSITIVE

Panacea Biotec experienced a significant financial turnaround in Q1 FY26, secured a major contract with UNICEF, and received overwhelmingly positive analyst ratings. These developments collectively signal a strong positive shift in the company's prospects and make it a compelling investment story for the month.

View Panacea Biotec News Sentiment Analysis

Performance & Financial Health Analysis: Bharat vs Panacea Biotec

MetricBIBCLPANACEABIO
Market Information
Market Cap i₹910.67M₹26.29B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i16,386236,929
90 Day Avg. Volume i25,808210,411
Last Close₹21.13₹431.75
52 Week Range₹19.00 - ₹35.88₹271.20 - ₹581.90
% from 52W High-41.11%-25.80%
All-Time High₹94.50 (Jun 14, 2021)₹581.90 (Apr 28, 2025)
% from All-Time High-77.64%-25.80%
Growth Metrics
Quarterly Revenue Growth-0.99%0.44%
Quarterly Earnings Growth-1.00%0.44%
Financial Health
Profit Margin (TTM) i-2.42%0.02%
Operating Margin (TTM) i-28.88%-0.06%
Return on Equity (TTM) i-0.21%-0.01%
Debt to Equity (MRQ) i94.482.67
Cash & Liquidity
Book Value per Share (MRQ)₹18.24₹136.92
Cash per Share (MRQ)₹2.07₹17.95
Operating Cash Flow (TTM) i₹87.48M₹-1,511,860,000
Levered Free Cash Flow (TTM) i₹-166,388,000₹-83,700,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Bharat vs Panacea Biotec

MetricBIBCLPANACEABIO
Price Ratios
P/E Ratio (TTM) i-5.48222.06
Forward P/E iN/AN/A
PEG Ratio i-0.09-1.77
Price to Sales (TTM) i11.764.17
Price to Book (MRQ) i1.163.03
Market Capitalization
Market Capitalization i₹910.67M₹26.29B
Enterprise Value i₹1.56B₹24.56B
Enterprise Value Metrics
Enterprise to Revenue i20.454.03
Enterprise to EBITDA i-7.87-195.08
Risk & Other Metrics
Beta i0.910.30
Book Value per Share (MRQ) i₹18.24₹136.92

Financial Statements Comparison: Bharat vs Panacea Biotec

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BIBCLPANACEABIO
Revenue/Sales i₹0₹1.67B
Cost of Goods Sold i₹0₹772.20M
Gross Profit i₹0₹894.80M
Research & Development iN/AN/A
Operating Income (EBIT) i₹-47.23M₹-95.70M
EBITDA i₹-45.25M₹44.90M
Pre-Tax Income i₹-66.46M₹65.60M
Income Tax i₹-17.28M₹26.00M
Net Income (Profit) i₹-49.18M₹39.60M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BIBCLPANACEABIO
Cash & Equivalents i₹14.58M₹821.25M
Total Current Assets i₹327.10M₹5.45B
Total Current Liabilities i₹990.55M₹3.67B
Long-Term Debt i₹35.00M₹150.00M
Total Shareholders Equity i₹787.09M₹8.31B
Retained Earnings iN/A₹7.80B
Property, Plant & Equipment iN/A₹5.43B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BIBCLPANACEABIO
Operating Cash Flow i₹-708.65MN/A
Capital Expenditures iN/AN/A
Free Cash Flow i₹-456.88MN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBIBCLPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i16,386236,929
Average Daily Volume (90 Day) i25,808210,411
Shares Outstanding i43.18M61.25M
Float Shares i17.58M15.45M
% Held by Insiders i0.59%0.73%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: Bharat vs Panacea Biotec

MetricBIBCLPANACEABIO
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A